xylazine has been researched along with Adrenal Cancer in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Before treatment of the hyperadrenocorticism, no significant increase in growth hormone concentration occurred in any of the dogs following the administration of xylazine." | 1.26 | Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment. ( Altszuler, N; Peterson, ME, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, ME | 1 |
| Altszuler, N | 1 |
1 other study available for xylazine and Adrenal Cancer
| Article | Year |
|---|---|
Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Animals; Cushing Syndrome; Dog Disea | 1981 |